Stocktoria
NU SKIN ENTERPRISES, INC. NUS
NYSE · XNYS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries · website · IPO 1996-11-22
NU SKIN ENTERPRISES, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.5B | $1.7B | $2.0B | $2.2B | $2.7B |
| Gross profit | $1.0B | $1.2B | $1.4B | $1.6B | $2.0B |
| R&D expense | $10.8M | $13.0M | $22.6M | $23.3M | $27.2M |
| Operating income | $65.8M | -$151.6M | $48.3M | $110.8M | $234.0M |
| Interest expense | — | — | $25.6M | $13.5M | $11.0M |
| Income tax | $36.0M | -$28.5M | $18.0M | -$15.8M | $85.2M |
| Net income | $160.2M | -$146.6M | $8.6M | $104.8M | $147.3M |
| EPS (diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
| Operating cash flow | $80.3M | $111.7M | $118.6M | $108.1M | $141.6M |
| Free cash flow | $46.0M | $70.2M | $60.1M | $49.0M | $73.0M |
| Cash & equivalents | $238.6M | $186.9M | $256.1M | $264.7M | $339.6M |
| Inventory | $178.6M | $190.2M | $280.0M | $346.2M | $399.9M |
| Total assets | $1.4B | $1.5B | $1.8B | $1.8B | $1.9B |
| Total liabilities | $600.1M | $817.5M | $986.7M | $923.7M | $993.7M |
| Shareholders' equity | $805.2M | $651.5M | $822.0M | $897.3M | $912.8M |
Source: SEC EDGAR filings · CIK 0001021561 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.